A 3-month, Multicenter, Randomized, Open-label Study to Evaluate the Impact on Wound Healing of the Early (vs Delayed) Introduction of Everolimus in De Novo Kidney Transplant Recipients, With a Follow-up Evaluation at 12 Months After Transplant (NEVERWOUND Study)

BACKGROUND. The risk of wound healing complications (WHCs) and the early use of mammalian target of rapamycin inhibitors after kidney transplantation (KT) have not been fully addressed. METHODS. The NEVERWOUND study is a 3-month, multicenter, randomized, open-label study designed to evaluate whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzia, Tommaso Maria, Carmellini, Mario, Todeschini, Paola, Secchi, Antonio, Sandrini, Silvio, Minetti, Enrico, Furian, Lucrezia, Spagnoletti, Gionata, Pisani, Francesco, Piredda, Gian Benedetto, Cappelli, Gianni, Tisone, GIuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Clinical Science—General
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004468/
https://www.ncbi.nlm.nih.gov/pubmed/31335776
http://dx.doi.org/10.1097/TP.0000000000002851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004468/
https://www.ncbi.nlm.nih.gov/pubmed/31335776
http://dx.doi.org/10.1097/TP.0000000000002851

Ejemplares similares